Sandoz Can't Escape Teva's Copaxone Patent Suit
Sandoz Inc. and Momenta Pharmaceuticals Inc. have lost their bid to upend Teva Pharmaceuticals USA Inc.'s suit accusing the generic-drug makers of infringing several patents in their effort to manufacture a...To view the full article, register now.
Already a subscriber? Click here to view full article